UNSPSC 51373313: Acetaminophen/meperidine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373313 Acetaminophen/meperidine, a Commodity code, reflects state and local procurement of pharmaceuticals and related health products, though recent opportunities tagged under this code show activity spanning naloxone distribution, direct-to-manufacturer prescription programs, and multi-source generic pharmaceutical supply agreements rather than acetaminophen or meperidine specifically. State and local issuing bodies soliciting under this code include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. Seminole County, Florida, for example, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB (IFB60459723LAS, due July 26, 2023), while the Texas Health and Human Services Commission issued an RFI (HHS0017013, April 3, 2026) to explore direct-to-manufacturer prescription program capabilities and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across multiple state and local participating facilities in Minnesota and Oregon.

The code shows recent activity concentrated in Florida, Texas, and Minnesota, with multistate cooperative purchasing extending coverage across additional jurisdictions including Oregon. The MMCAP procurement is the largest in scope, establishing multiple contracts for generic pharmaceuticals distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with pricing weighted 75 percent on competitiveness, 10 percent on fixed pricing, and 5 percent each on administrative fee compliance, EDI capability, and data format requirements. Vendors must certify cGMP and Drug Supply Chain Security Act compliance, maintain relationships with at least two of three wholesalers, and carry commercial general liability insurance of $5 million per occurrence. The Seminole County naloxone IFB required electronic bidding through the county's e-procurement portal with drug-free workplace certification and E-Verify compliance, potentially funded through FEMA. The Texas RFI represents exploratory procurement seeking vendor capabilities for direct contracting models outside traditional PBM and GPO arrangements, suggesting the state is developing strategy before issuing formal RFPs with defined pricing and timelines.